• Gambro Renal Products (GRP; Lakewood, Colorado), a business of the Gambro Group, reported receiving FDA 510(k) clearance for a treatment that removes toxins from the blood in cases of drug overdose and poisoning. Gambro’s Molecular Adsorbents Recirculating System (MARS) Therapy is a blood detoxification system used in conjunction with an extracorporeal device for the treatment of drug overdose and poisonings. MARS Therapy uses albumin as the primary agent for removing dialyzable (unbound) toxins. During MARS Therapy, a patient is connected to the Gambro Prisma system, a Continuous Renal Replacement Therapy (CRRT) system, which pushes blood through an extracorporeal circuit into a MARS Flux filter. Based on a process called albumin dialysis, the filter removes toxins with an affinity for protein by diffusion into a recirculating human albumin solution. Gambro Renal said that the MARS Therapy will be available in the U.S. “toward the end” of 2005 for drug overdose and poisoning treatment. • GE Healthcare(Waukesha, Wisconsin) reported launch of its new family of LightSpeed computed tomography systems that now include exclusive Volara digital Data Acquisition System (DAS), and the Xtream FX workflow platform. The rollout was made at the 7th Annual International Symposium on Multidetector-Row CT (MRCT), presented by the Department of Radiology at the Stanford University School of Medicine. The LightSpeed VFX Series will utilize the Volara digital DAS technology and Xtream FX workflow platform, developed for GE’s LightSpeed VCT. The company said that, with these instruments, “clinicians will be able to tap many of the unprecedented images quality and productivity capabilities of the LightSpeed VCT on GE’s 4, 8 and 16 slice CT systems.” Included in the LightSpeed VFX series is the Wide Open Workflow with Xtream* FX, the second generation of Xtream workflow technology, enabling imaging departments, it said, “the ability to keep pace with the large volume of data generated by MDCT systems.• MDS Nordion(Ottawa) reported commercial availability of copper-64 (Cu-64). Cu-64 is principally used as a positron emission tomography (PET) imaging isotope that, it said, provides physicians with higher resolution images to better diagnose and monitor disease. Cu-64 is a “long-lived” PET isotope with a half-life of 12.7 hours and can be distributed commercially, eliminating the need for users to have an on-site isotope production facility. In addition, Cu-64 use in molecular imaging and biodistribution studies are becoming part of the drug development process as well as possible therapeutic applications for the treatment of disease. MDS said that the nuclear medicine, biotech and pharma communities “now have a dependable and secure supply of Cu-64.”Building on its experience as a global leader in radioisotope supply and radiopharmaceutical manufacturing,MDS Nordion is expanding its range of products and services to support innovation and optimize the drug discovery and development process. By offering integrated services to support the discovery and pre-clinical development of diagnostic and therapeutic radiopharmaceuticals, as well as molecular imaging applications, MDS Nordion said it is helping biotechnology and pharmaceutical companies to bring products to market faster. MDS Nordion describes itself as “a world leader in radioisotopes, radiation and related technologies.”• Swissray International(Lizabeth, New Jersey) reported that it has received FDA 510(k) clearance to market its newest direct digital radiographic system, the ddRCombi Trauma. The ddRCombi Trauma is engineered to provide fast, high-quality digital imaging in the emergency department or trauma center. With this system, traumatized patients can be imaged from head to toe without being moved. The ddRCombi Trauma features a fixed table with elevating base, four-way floating top, and automatic positioning of the detector for cross table imaging with the push of a single button on a wireless hand-held remote control. The table top easily slides away for access to the digital detector for wheel chair and upright exams. The system includes the eXpert4000 control and communication center. A memory function enables fully programmable user functions, including automatic positioning for every body part as well as from existing images on SwissVision. It is fully remote monitoring capable.